Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,861 | 116 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $789.65 | 11 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $370.75 | 10 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $286.31 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $281.61 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $228.35 | 14 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $184.59 | 6 | $0 (2024) |
| Novo Nordisk Inc | $172.61 | 5 | $0 (2024) |
| ABBVIE INC. | $114.58 | 6 | $0 (2024) |
| UROGEN PHARMA, INC. | $108.93 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $106.61 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,268 | 49 | Sumitomo Pharma America, Inc. ($265.70) |
| 2023 | $1,487 | 38 | Myriad Genetic Laboratories, Inc. ($530.23) |
| 2022 | $693.94 | 21 | GlaxoSmithKline, LLC. ($217.19) |
| 2021 | $411.86 | 8 | BOSTON SCIENTIFIC CORPORATION ($102.73) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.27 | General |
| Category: Prostate cancer | ||||||
| 12/04/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: HORMONE THERAPY | ||||||
| 11/20/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $28.86 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $87.27 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Rare Disease | ||||||
| 07/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: UROLOGY | ||||||
| 07/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Oncology | ||||||
| 06/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,741 | 2,226 | $197,536 | $69,488 |
| 2022 | 6 | 126 | 191 | $6,219 | $1,324 |
| 2021 | 9 | 277 | 412 | $14,512 | $2,953 |
| 2020 | 9 | 349 | 487 | $18,063 | $3,690 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 295 | $50,445 | $22,584 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 317 | $36,455 | $17,019 | 46.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 17 | 17 | $11,883 | $3,313 | 27.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 45 | 57 | $13,509 | $2,640 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,550 | $2,607 | 39.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 103 | 111 | $8,991 | $1,955 | 21.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 23 | 24 | $6,600 | $1,782 | 27.0% |
| 87799 | Detection test by nucleic acid for organism, quantification | Office | 2023 | 13 | 40 | $5,280 | $1,679 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,056 | $1,672 | 41.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 45 | $3,105 | $1,575 | 50.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 32 | 32 | $7,360 | $1,549 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 155 | 181 | $2,172 | $1,512 | 69.6% |
| 87900 | Infectious agent drug susceptibility analysis | Office | 2023 | 11 | 11 | $3,575 | $1,405 | 39.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 434 | 610 | $6,100 | $1,333 | 21.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 111 | 148 | $7,548 | $1,076 | 14.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 21 | 28 | $5,824 | $1,049 | 18.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 14 | 30 | $3,240 | $1,032 | 31.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 19 | $1,330 | $599.45 | 45.1% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 14 | 15 | $1,620 | $515.85 | 31.8% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 14 | 15 | $1,620 | $515.85 | 31.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 48 | 51 | $1,887 | $417.01 | 22.1% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 11 | 11 | $1,188 | $378.29 | 31.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 43 | 48 | $1,632 | $353.78 | 21.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 12 | 13 | $2,184 | $308.21 | 14.1% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 16 | 16 | $1,296 | $288.32 | 22.2% |
About Lisa Vinal, NP
Lisa Vinal, NP is a Family healthcare provider based in Millinocket, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1316211469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Vinal, NP has received a total of $3,861 in payments from pharmaceutical and medical device companies, with $1,268 received in 2024. These payments were reported across 116 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,861).
As a Medicare-enrolled provider, Vinal has provided services to 2,493 Medicare beneficiaries, totaling 3,316 services with total Medicare billing of $77,455. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Millinocket, ME
- Active Since 03/06/2012
- Last Updated 06/17/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1316211469
Products in Payments
- MYRISK (Device) $627.31
- PROVENGE (Drug) $370.75
- TRELEGY ELLIPTA (Drug) $228.35
- ERLEADA (Drug) $221.16
- Nubeqa (Drug) $184.59
- ORGOVYX (Drug) $183.40
- BRAC CDx (Device) $110.96
- JELMYTO (Drug) $108.93
- XARELTO (Drug) $106.61
- Omnia (Device) $103.40
- GEMTESA (Drug) $102.91
- WATCHMAN (Device) $102.73
- FARXIGA (Drug) $99.68
- LUPRON DEPOT (Drug) $99.37
- Wegovy (Drug) $95.24
- Repatha (Biological) $86.56
- KEYTRUDA (Biological) $78.92
- TRULANCE (Drug) $74.71
- NEXLIZET (Drug) $73.77
- Trelstar (Drug) $72.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.